Literature DB >> 6806932

The binding of purified factor VIII/von Willebrand factor to collagens of differing type and form.

D M Scott, B Griffin, D S Pepper, M J Barnes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6806932     DOI: 10.1016/0049-3848(81)90080-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  7 in total

Review 1.  Factor VIII/von Willebrand factor: a multivalent ligand binding to platelets and collagen.

Authors:  M Furlan
Journal:  Blut       Date:  1986-06

2.  Synthesis and expression of the fibroblast fibronectin receptor in human monocytes.

Authors:  D L Brown; D R Phillips; C H Damsky; I F Charo
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

3.  Von Willebrand protein binds to extracellular matrices independently of collagen.

Authors:  D D Wagner; M Urban-Pickering; V J Marder
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

4.  Structural basis of von Willebrand factor binding to platelet glycoprotein Ib and collagen. Effects of disulfide reduction and limited proteolysis of polymeric von Willebrand factor.

Authors:  P Bockenstedt; J M Greenberg; R I Handin
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

5.  Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen.

Authors:  P G de Groot; M Ottenhof-Rovers; J A van Mourik; J J Sixma
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

6.  Binding and covalent cross-linking of purified von Willebrand factor to native monomeric collagen.

Authors:  P Bockenstedt; J McDonagh; R I Handin
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

7.  Static spatial growth restriction micropatterning of endothelial colony forming cells influences their morphology and gene expression.

Authors:  Matthew W Hagen; Monica T Hinds
Journal:  PLoS One       Date:  2019-06-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.